Intestinal Neuroendocrine Neoplasm — Trials

Intestinal Neuroendocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02595424	Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas	active not recruiting	Phase 2	67	ECOG-ACRIN Cancer Research GroupNETWORK	1	Jul 27, 2026	clinicaltrials
NCT02834013	Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	active not recruiting	Phase 2	798	National Cancer Institute (NCI)NIH	2	Jun 17, 2026	clinicaltrials
NCT04579679	Open-Label Surufatinib in European Patients With NET	terminated	Phase 2	78	HutchmedINDUSTRY	7	Jul 25, 2025	clinicaltrials
NCT02420691	Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

Data updated 23 days agoSource updated Jul 27, 2026source: clinicaltrials